Lenny van Bon

1.4k total citations
20 papers, 664 citations indexed

About

Lenny van Bon is a scholar working on Immunology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Lenny van Bon has authored 20 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Pathology and Forensic Medicine and 7 papers in Rheumatology. Recurrent topics in Lenny van Bon's work include Systemic Sclerosis and Related Diseases (9 papers), Mast cells and histamine (5 papers) and Immune Response and Inflammation (4 papers). Lenny van Bon is often cited by papers focused on Systemic Sclerosis and Related Diseases (9 papers), Mast cells and histamine (5 papers) and Immune Response and Inflammation (4 papers). Lenny van Bon collaborates with scholars based in Netherlands, United States and Italy. Lenny van Bon's co-authors include Timothy R. D. J. Radstake, Mark H. Wenink, Kim C. M. Santegoets, Jasper Broen, Yanhui Deng, Robert Lafyatis, Timothy R. D. J. Radstake, Marta Cossu, Erik Lubberts and Lorenzo Beretta and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Lenny van Bon

19 papers receiving 657 citations

Peers

Countries citing papers authored by Lenny van Bon

Since Specialization

Citations

This map shows the geographic impact of Lenny van Bon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lenny van Bon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lenny van Bon more than expected).

Fields of papers citing papers by Lenny van Bon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lenny van Bon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lenny van Bon. The network helps show where Lenny van Bon may publish in the future.

Co-authorship network of co-authors of Lenny van Bon

This figure shows the co-authorship network connecting the top 25 collaborators of Lenny van Bon. A scholar is included among the top collaborators of Lenny van Bon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lenny van Bon. Lenny van Bon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Atherosclerotic cardiovascular disease in systemic lupus erythematosus: from preclinical lupus to atherosclerotic plaque erosion 2025 ·Rheumatology Advances in Practice ·Sander I. van Leuven, Lenny van Bon, Robin Nijveldt, Amy S. Major	1
2	An in-depth comparison of vascular inflammation on ultrasound, FDG-PET/CT and MRI in patients with suspected giant cell arteritis 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), P. H. Nienhuis, C.J. Haagsma, Kornelis S. M. van der Geest, (unknown), Auke P.A. Appelman, (unknown), Lenny van Bon, Edgar M. Colin, Elisabeth Brouwer, Riemer H. J. A. Slart, (unknown)	0
3	Investigating interferon type I responses in patients with suspected giant cell arteritis and polymyalgia rheumatica 2024 ·Clinical & Experimental Immunology ·(unknown), A. H. L. Mulder, Edgar M. Colin, (unknown), Lenny van Bon, Elisabeth Brouwer	2
4	Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients 2023 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Wayel H. Abdulahad, Yannick van Sleen, William F. Jiemy, Maria Sandovici, (unknown), Lenny van Bon	6
5	External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic 2023 ·RMD Open ·(unknown), Lenny van Bon, (unknown), (unknown), (unknown)	10
6	Implication of miR-126 and miR-139-5p in Plasmacytoid Dendritic Cell Dysregulation in Systemic Sclerosis 2021 ·Journal of Clinical Medicine ·Eleni Chouri, Maojie Wang, Maarten R. Hillen, Chiara Angiolilli, Sandra C. Silva‐Cardoso, Catharina G. K. Wichers, Maarten van der Kroef, Cornelis P. J. Bekker, Marta Cossu, Lenny van Bon, Alsya J. Affandi, Tiago Carvalheiro, Aridaman Pandit, Joël A. G. van Roon, Lorenzo Beretta, Boudewijn Burgering, Timothy R. D. J. Radstake, Marzia Rossato	23
7	Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis 2019 ·Annals of the Rheumatic Diseases ·Alsya J. Affandi, Tiago Carvalheiro, Andrea Ottria, (unknown), Lara Bossini‐Castillo, (unknown), Lenny van Bon, Eleni Chouri, Marzia Rossato, Jorre S. Mertens, Samuel García, Aridaman Pandit, (unknown), Romy Christmann, Javier Martı́n, (unknown), Timothy R. D. J. Radstake, Wioleta Marut	20
8	Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum 2017 ·Arthritis & Rheumatology ·Marta Cossu, Lenny van Bon, (unknown), Marzia Rossato, Lorenzo Beretta, Timothy R. D. J. Radstake	34
9	Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: another role for CXCL4? 2016 ·Lara D. Veeken ·Lenny van Bon, Marta Cossu, Alwin Scharstuhl, (unknown), Madelon C Vonk, Hendrik J. Vreman, (unknown), W. van den Berg, Frank A. D. T. G. Wagener, Timothy R. D. J. Radstake	16
10	The magnitude of cytokine production by stimulated CD56+ cells is associated with early stages of systemic sclerosis 2016 ·Clinical Immunology ·Marta Cossu, Lenny van Bon, Stefan Nierkens, Chiara Bellocchi, Alessandro Santaniello, Harry Dolstra, Lorenzo Beretta, Timothy R. D. J. Radstake	22
11	The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis 2015 ·Annals of the Rheumatic Diseases ·Zana Brkić, Lenny van Bon, Marta Cossu, Cornelia G van Helden-Meeuwsen, Madelon C Vonk, Hanneke Knaapen, W. van den Berg, Virgil A. S. H. Dalm, Paul Van Daele, Adriana Severino, Naomi I. Maria, (unknown), Willem A. Dik, Lorenzo Beretta, Marjan A. Versnel, Timothy R. D. J. Radstake	131
12	Soluble Immune Complexes Shift the TLR-Induced Cytokine Production of Distinct Polarized Human Macrophage Subsets towards IL-10 2012 ·PLoS ONE ·Carmen A. Ambarus, Kim C. M. Santegoets, Lenny van Bon, Mark H. Wenink, Paul P. Tak, Timothy R. D. J. Radstake, Dominique Baeten	51
13	Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis 2011 ·Arthritis & Rheumatism ·Mark H. Wenink, Kim C. M. Santegoets, John Butcher, Lenny van Bon, (unknown), Wim B. van den Berg, Piet L. C. M. van Riel, Iain B. McInnes, Timothy R. D. J. Radstake	23
14	Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis 2011 ·Journal of Translational Medicine ·Mark H. Wenink, Kim C. M. Santegoets, John Butcher, Lenny van Bon, (unknown), Wim B. van den Berg, Piet L. van Riel, Iain B. McInnes, Timothy R. D. J. Radstake	5
15	TLR2 Promotes Th2/Th17 Responses via TLR4 and TLR7/8 by Abrogating the Type I IFN Amplification Loop 2009 ·The Journal of Immunology ·Mark H. Wenink, Kim C. M. Santegoets, (unknown), Lenny van Bon, Shahla Abdollahi‐Roodsaz, Călin D. Popa, Richard Huijbens, (unknown), Erik Lubberts, Piet L. C. M. van Riel, Wim B. van den Berg, Timothy R. D. J. Radstake	52
16	The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGFβ and IFNγ Distinguishes SSc Phenotypes 2009 ·PLoS ONE ·Timothy R. D. J. Radstake, Lenny van Bon, Jasper Broen, (unknown), Roger Hesselstrand, Dirk M. Wuttge, Yanhui Deng, (unknown), Erik Lubberts, Robert Lafyatis	133
17	Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGFβ Expression 2009 ·PLoS ONE ·Timothy R. D. J. Radstake, Lenny van Bon, Jasper Broen, Mark H. Wenink, Kim C. M. Santegoets, Yanhui Deng, (unknown), Robert W. Simms, William W. Cruikshank, Robert Lafyatis	131
18	F.122. Toll Like Receptor 2 Promotes Th2/Th17 Responses via TLR4 and TLR8 by Human Dendritic Cells by Abrogating the Type 1 Interferon Amplification Loop 2009 ·Clinical Immunology ·Mark H. Wenink, Kim C. M. Santegoets, Lenny van Bon, Jasper Broen, Richard Huijbens, Erik Lubberts, Piet L. C. M. van Riel, W. van den Berg, Timothy R. D. J. Radstake	1
19	F.116. The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGFβ and IFNγ Distinguishes Different SSc Clinical Phenotypes 2009 ·Clinical Immunology ·Timothy R. D. J. Radstake, Lenny van Bon, Jasper Broen, (unknown), Roger Hesselstrand, Dirk M. Wuttge, Yanhui Deng, Robert W. Simms, Erik Lubberts, Robert Lafyatis	2
20	S.70. Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSC) is Related to Diminished CD69 and TGFβ Expression 2009 ·Clinical Immunology ·Timothy R. D. J. Radstake, Lenny van Bon, Jasper Broen, Mark H. Wenink, Kim C. M. Santegoets, Yanhui Deng, (unknown), Robert W. Simms, William W. Cruikshank, Robert Lafyatis	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact